AbCellera Biologics Inc.
(ABCL)
AbCellera Turned Itself Into a One-Drug Company, and the One Drug Is Working
What kills single-asset biotechs is not usually the science; it is being forced to sell equity into bad news and AbCellera has removed that mechanism for the window in question.
Read Article ›